HCPCS code J2508 — Pegunigalsidase alfa-iwxj. Status: Active. Effective Jan 1, 2024. Source: CMS HCPCS Level II.

J2508

Active

Pegunigalsidase alfa-iwxj

Injection, pegunigalsidase alfa-iwxj, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2024
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0715

MUE — Medically Unlikely Edits

Maximum units of J2508 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 160
Practitioner Services 160

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
10122-0160-02 Elfabrio
10122-0160-05 Elfabrio
10122-0160-10 Elfabrio
10122-0165-02 Elfabrio

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q1
    Pegunigalsidase alfa-iwxj